Sign In
Last checked at 
6 Oct 2011 15:26
Hikma Pharmaceuticals PLC
Interim Dividend for 2011
LONDON, 6 October 2011 - Hikma Pharmaceuticals PLC ("the Company") advises that, as previously announced with the interim results, the interim dividend of 5.5 cents per will be paid on 13 October 2011 to shareholders on the register on 9 September 2011.
Shareholders who have elected to receive their dividend in Pounds Sterling will receive 3.555 pence per Ordinary Share (exchange rate US$1.5470 to GBP£1).
Shareholders who have elected to receive their dividend in Jordanian Dinar will receive 7.768 qirsh (piastres) per Ordinary Share (exchange rate US$0.708 to JOD1).
- ENDS -
Enquiries:
Hikma Pharmaceuticals PLC | |
Henry Knowles Company Secretary
| +44 20 7399 2670 |
Susan Ringdal Investor Relations Director
| +44 20 7399 2670
|
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed pharmaceutical products. Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics". Hikma's operations are based principally in the Middle East and North Africa ("MENA") region, where it is a market leader and sells across 17 countries, the United States and Europe. In 2010, the Group achieved revenues of $731 million (2009 $637 million) and profit attributable to shareholders was $99 million (2009 $78 million).
Follow the stocks
